Skip to main content

Table 2 Comparison of clinical features between the PKD patients with and without PRRT2 mutations

From: Clinical features of patients with paroxysmal kinesigenic dyskinesia, mutation screening of PRRT2 and the effects of morning draughts of oxcarbazepine

 

patients with PRRT2 mutations

patients without PRRT2 mutations

p

No. of subjects

5

15

 

Male(%)

4(80%)

13(86.7%)

1.000

Age at onset (years)

  

0.502

 Mean (SD)

7.1(3)

8.4(3.7)

 

 Median

7

9

 

Main phenotype, n

  

0.338

 Choreoathetosis

2

2

 

 Dystonia

1

9

 

 Mixed

2

4

 

Laterality of dyskinesia

  

0.530

 Unilateral

0

4

 

 Biateral

5

11

 

Involved limb

  

0.805

 Upper limbs

0

3

 

 Lower limbs

2

6

 

 Both

3

6

 

Frequency of attack/day, n

  

0.805

 < 5

2

6

 

 5–10

3

6

 

 > 10

0

3

 

Comorbidity

3

1

0.032

  1. P* < 0.05